BAFF Antilichaam [Buffy-1] (FITC)

10673

Q9Y275

Human

BAFF (monoclonal Buffy-1) antibody was raised against recombinant human soluble BAFF (aa. 83-285) .

Buffy-1

FITC

Primary Antibodies

Chemokines & Cytokines, Cancer

Anti BAFF (monoclonal Buffy-1) antibody was purified to ≥95% in SDS-PAGE.

Batch dependent

PBS containing 0.02% sodium azide

None

Blue Ice

BAFF antibody can be stored at 4˚ C, stable for one year.

IgG2a

BAFF antibody detects endogenous protein by Flow Cytometry. Method: 293T cells (5 x 105) expressing surface BAFF vector or Mock transfected, were incubated on ice for 30 min in 50 μ l FACS buffer (PBS, 5% fetal calf serum, 0.02% azide) containing 4 μ g/mL of Buffy-1 antibody. After washing in FACS buffer, FITC-conjugated antibody to rat IgG was added and cells were analyzed by flow cytometry.

Tumor necrosis factor (ligand) superfamily, member 13b

Homo sapiens

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth: P. Schneider, et al.; J. Exp. Med. 189, 1747 (1999) .

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population: J.S. Thompson, et al.; J. Exp. Med. 192, 129 (2000) .

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth: P. Rennert, et al.; J. Exp. Med. 192, 1677 (2000) .

Flow

Liquid